Correction to: Leukemia (2017) 31, 2315–2325; doi:https://doi.org/10.1038/leu.2017.64; published online 10 March 2017
Following the publication of this article, the authors noted a mistake in the author affiliations.
4. Centre for Research in Molecular Medicine, The University of Lahore, Lahore, Pakistan
Should be replaced with:
4. University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi, Pakistan
The authors apologise for any inconvenience this might have caused.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/leu.2017.64
Rights and permissions
About this article
Cite this article
Dell'Aversana, C., Giorgio, C., D'Amato, L. et al. Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis. Leukemia 32, 573 (2018). https://doi.org/10.1038/leu.2017.310
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.310
This article is cited by
-
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
Molecular Cancer (2022)
-
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
Cancer Cell International (2019)
-
High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia
Cancer Cell International (2019)
